UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Malaria in Southern Venezuela: The hottest hotspot in Latin America

PLoS neglected tropical diseases, 2021-01, Vol.15 (1), p.e0008211

2021

Volltextzugriff (PDF)

Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants

American journal of transplantation, 2017-11, Vol.17 (11), p.2945-2954

2017

Volltextzugriff (PDF)

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

American journal of transplantation, 2010-05, Vol.10 (5), p.1228-1237

2010

Volltextzugriff (PDF)

Three‐Year Outcomes from BENEFIT, a Randomized, Active‐Controlled, Parallel‐Group Study in Adult Kidney Transplant Recipients

American journal of transplantation, 2012-01, Vol.12 (1), p.210-217

2012

Volltextzugriff (PDF)

Beyond Belatacept: Praise and Progress for the FDA

American journal of transplantation, 2012-03, Vol.12 (3), p.513-514

Vincenti, F.

2012

Volltextzugriff (PDF)

Spatial Analysis of Dengue Seroprevalence and Modeling of Transmission Risk Factors in a Dengue Hyperendemic City of Venezuela

PLoS neglected tropical diseases, 2017-01, Vol.11 (1), p.e0005317-e0005317

2017

Volltextzugriff (PDF)

A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients

American journal of transplantation, 2008-02, Vol.8 (2), p.307-316

2008

Volltextzugriff (PDF)

ENSO-driven climate variability promotes periodic major outbreaks of dengue in Venezuela

Scientific reports, 2018-04, Vol.8 (1), p.5727-11, Article 5727

2018

Volltextzugriff (PDF)

Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti‐LFA‐1 Antibody Efalizumab

American journal of transplantation, 2010-08, Vol.10 (8), p.1870-1880

2010

Volltextzugriff (PDF)

Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study

American journal of transplantation, 2013-01, Vol.13 (1), p.136-145

2013

Volltextzugriff (PDF)

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

American journal of transplantation, 2010-03, Vol.10 (3), p.535-546

2010

Volltextzugriff (PDF)

Randomized Phase 2b Trial of Tofacitinib (CP‐690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year

American journal of transplantation, 2012-09, Vol.12 (9), p.2446-2456

2012

Volltextzugriff (PDF)

Systemic oxidative stress associates with the development of post-COVID-19 syndrome in non-hospitalized individuals

Redox biology, 2024-10, Vol.76, p.103310, Article 103310

2024

Volltextzugriff (PDF)

dLLME-μSPE extraction coupled to HPLC-ESI-MS/MS for the determination of F2α-IsoPs in human urine

Journal of pharmaceutical and biomedical analysis, 2020-07, Vol.186, p.113302-113302, Article 113302

2020

Volltextzugriff (PDF)

A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)

American journal of transplantation, 2010-03, Vol.10 (3), p.547-557

2010

Volltextzugriff (PDF)

Health Seeking Behaviour and Treatment Intentions of Dengue and Fever: A Household Survey of Children and Adults in Venezuela

PLoS neglected tropical diseases, 2015-12, Vol.9 (12), p.e0004237-e0004237

2015

Volltextzugriff (PDF)

Long‐Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long‐Term Extension of the BENEFIT Study

American journal of transplantation, 2013-11, Vol.13 (11), p.2875-2883

2013

Volltextzugriff (PDF)

What's Next in the Pipeline

American journal of transplantation, 2008-10, Vol.8 (10), p.1972-1981

2008

Volltextzugriff (PDF)

Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients

Transplantation proceedings, 2017-10, Vol.49 (8), p.1773-1778

2017

Volltextzugriff (PDF)

Steroid‐Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials

American journal of transplantation, 2016-11, Vol.16 (11), p.3077-3078

2016

Volltextzugriff (PDF)

Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

American journal of transplantation, 2007-06, Vol.7 (6), p.1506-1514

2007

Volltextzugriff (PDF)

An integrated safety profile analysis of belatacept in kidney transplant recipients

Transplantation, 2010-12, Vol.90 (12), p.1521-1527

2010

Volltextzugriff (PDF)

Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients

American journal of transplantation, 2009-08, Vol.9 (8), p.1936-1945

2009

Volltextzugriff (PDF)

Immunosuppression with Belatacept‐Based, Corticosteroid‐Avoiding Regimens in De Novo Kidney Transplant Recipients

American journal of transplantation, 2011-01, Vol.11 (1), p.66-76

2011

Volltextzugriff (PDF)

Ten‐year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4‐weekly or 8‐weekly

American journal of transplantation, 2017-12, Vol.17 (12), p.3219-3227

2017

Volltextzugriff (PDF)

1 – 25 von 790

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(645)
Mit Volltextzugriff
(508)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(454)
Humans
(379)
Life Sciences & Biomedicine
(378)
Female
(229)
Male
(214)
Adult
(177)
Biological And Medical Sciences
(170)
Middle Aged
(160)
Medical Sciences
(157)
Surgery
(152)
Transplantation
(136)
Kidney Transplantation
(109)
Aged
(97)
Immunology
(92)
Immunosuppressive Agents - Therapeutic Use
(67)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(66)
Physical Sciences
(59)
Adolescent
(57)
Pharmacology. Drug Treatments
(55)
Graft Survival
(54)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Malaria in Southern Venezuela: The hottest hotspot in Latin America

Polyclonal Regulatory T Cell Therapy for Control of Inflammation in Kidney Transplants

The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High‐Risk Kidney Transplant Recipients

Three‐Year Outcomes from BENEFIT, a Randomized, Active‐Controlled, Parallel‐Group Study in Adult Kidney Transplant Recipients

Beyond Belatacept: Praise and Progress for the FDA

Spatial Analysis of Dengue Seroprevalence and Modeling of Transmission Risk Factors in a Dengue Hyperendemic City of Venezuela

A Randomized, Multicenter Study of Steroid Avoidance, Early Steroid Withdrawal or Standard Steroid Therapy in Kidney Transplant Recipients

ENSO-driven climate variability promotes periodic major outbreaks of dengue in Venezuela

Islet Transplantation in Type 1 Diabetics Using an Immunosuppressive Protocol Based on the Anti‐LFA‐1 Antibody Efalizumab

Polyomavirus BK Replication in De Novo Kidney Transplant Patients Receiving Tacrolimus or Cyclosporine: A Prospective, Randomized, Multicenter Study

A Phase III Study of Belatacept‐based Immunosuppression Regimens versus Cyclosporine in Renal Transplant Recipients (BENEFIT Study)

Randomized Phase 2b Trial of Tofacitinib (CP‐690,550) in De Novo Kidney Transplant Patients: Efficacy, Renal Function and Safety at 1 Year

Systemic oxidative stress associates with the development of post-COVID-19 syndrome in non-hospitalized individuals

dLLME-μSPE extraction coupled to HPLC-ESI-MS/MS for the determination of F2α-IsoPs in human urine

A Phase III Study of Belatacept Versus Cyclosporine in Kidney Transplants from Extended Criteria Donors (BENEFIT‐EXT Study)

Health Seeking Behaviour and Treatment Intentions of Dengue and Fever: A Household Survey of Children and Adults in Venezuela

Long‐Term Belatacept Exposure Maintains Efficacy and Safety at 5 Years: Results From the Long‐Term Extension of the BENEFIT Study

What's Next in the Pipeline

Mycophenolate Mofetil Withdrawal With Conversion to Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients

Steroid‐Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials

Results of an International, Randomized Trial Comparing Glucose Metabolism Disorders and Outcome with Cyclosporine Versus Tacrolimus

An integrated safety profile analysis of belatacept in kidney transplant recipients

Calcineurin-Inhibitor-Free Immunosuppression Based on the JAK Inhibitor CP-690,550: A Pilot Study in De Novo Kidney Allograft Recipients

Immunosuppression with Belatacept‐Based, Corticosteroid‐Avoiding Regimens in De Novo Kidney Transplant Recipients

Ten‐year outcomes in a randomized phase II study of kidney transplant recipients administered belatacept 4‐weekly or 8‐weekly

Suchergebnisse filtern